Improvement in the Severity of Narcolepsy Symptoms and Fatigue in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)

Yves A Dauvilliers; RR Grunstein; Emmanuel Jean-Marie Mignot; G.J. Lammers; DT Plante; Erik Buntinx; Rafael del Río Villegas; H. Chen; Craig Hopkinson; Bhaskar Rege; M. Yountz; Michael Doane; Giuseppe Plazzi

doi:10.1016/j.sleep.2025.107526

Improvement in the Severity of Narcolepsy Symptoms and Fatigue in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)

Sleep Medicine 2026

View at publisher

Authors: Yves A Dauvilliers, RR Grunstein, Emmanuel Jean-Marie Mignot, G.J. Lammers, DT Plante, Erik Buntinx, Rafael del Río Villegas, H. Chen, Craig Hopkinson, Bhaskar Rege, M. Yountz, Michael Doane

+1 more

Giuseppe Plazzi

DOI: 10.1016/j.sleep.2025.107526

Cited by: 0

Fields of Study & Subjects

Sleep and Wakefulness Research Sleep and related disorders Sleep and Work-Related Fatigue

Publication details

Journal / source: Sleep Medicine
Volume: 138
Pages: 107526–107526
Publication date: 29 January 2026
Language: EN